argenx SE
$794.70
$16.39(-2.02%)
argenx SE
ARGX
$794.70
$16.39(-2.02%)
argenx SE
ARGX
NASDAQ
$794.70
$16.39(-2.02%)
Chart
Upcoming Earnings
Next report date
May 7, 2026
Report period
Q2 2026
EPS Estimate
$5.16
Revenue Estimate
$1.31B
Key stats
52-Week Range$794.70
$510.06
$934.62
Market capitalization
$49.18BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
42.60Basic EPS (TTM)
$38.32Net income (TTM)
$2.16BRevenue (TTM)
$5.49BAvg. volume
331.99KBeta (1Y)
-0.06Employees
1.60KMarket capitalization
$49.18BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
42.60Basic EPS (TTM)
$38.32Net income (TTM)
$2.16BRevenue (TTM)
$5.49BAvg. volume
331.99KBeta (1Y)
-0.06Employees
1.60KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout argenx SE
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy Van Hauwermeiren
Website
www.argenx.comHeadquarters
Laarderhoogtweg 25, Amsterdam, 1101EB
IPO Date
2017-05-18
Identifiers
ISIN
US04016X1019Description
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of...
Related Stocks
$702.27
1D:
-1.0%
1Y:
16.4%
US75886F1075Healthcare
Mkt Cap
$72.35B
P/E Ratio TTM
16.5
Revenue TTM
$14.34B
Beta
0.40
Earnings TTM
$4.50B
Dividend Yield TTM
0.51%
$144.17
1D:
-1.5%
1Y:
39.7%
US0758871091Healthcare
Mkt Cap
$52.23B
P/E Ratio TTM
24.2
Revenue TTM
$21.92B
Beta
0.35
Earnings TTM
$1.76B
Dividend Yield TTM
2.50%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate